Dr. Reddy's Files ANDA For Generic Tonmya

Dr. Reddy's Laboratories has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for a generic version of Tonmya, which is indicated for the treatment of fibromyalgia. The filing includes a Paragraph IV patent certification, indicating that Dr. Reddy's believes the patent covering the branded drug is invalid, unenforceable, or will not be infringed by its generic product.